Structural biomarkers identifiable on OCT-A can provide details regarding the development and progression of structural changes in MacTel 2.

Having both aqueous-deficient and evaporative dry eye, corneal pain, or a history of dry eye treatment can worsen quality of life.

The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.

Patients with suspected eyelid allergic contact dermatitis can benefit from patch testing beyond common allergens.